Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Somatostatin Receptor Imaging with [18F]FET-βAG-TOCA PET/CT and [68Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative StudySuraiya Dubash, Tara D Barwick, Kasia Kozlowski, et al.
Journal of Hepatology|February 20, 2025
A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancerJennifer J Knox, Mairéad G McNamara, Igor S Bazin, et al.
NEJM Evidence|February 6, 2024
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract CancerDo-Youn Oh, Aiwu Ruth He, Shukui Qin, et al.
Future Oncology (London, England)|September 25, 2023
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancerDo-Youn Oh, Aiwu Ruth He, Shukui Qin, et al.
European Journal of Endocrinology|June 15, 2026
Clinical Presentation and Outcomes of Sporadic Neuroendocrine Neoplasms in Young AdultsA Malczewska-Herman, A Rinke, P Holmager, et al.
JCI Insight|November 8, 2021
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetesCarla J Greenbaum, Elisavet Serti, Katharina Lambert, et al.
Physical Review Letters|March 10, 2023
Beam Energy Dependence of Fifth- and Sixth-Order Net-Proton Number Fluctuations in Au+Au Collisions at RHICB E Aboona, J Adam, L Adamczyk, et al.
Pageof 31